Published in J Invest Dermatol on August 01, 1987
Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells. J Exp Med (1990) 2.21
Birbeck granules are subdomains of endosomal recycling compartment in human epidermal Langerhans cells, which form where Langerin accumulates. Mol Biol Cell (2002) 1.21
The normal Langerhans cell and the LCH cell. Br J Cancer Suppl (1994) 1.06
Associated expression of CD1 antigen and Fc receptor for IgE on epidermal Langerhans cells from patients with atopic dermatitis. Clin Exp Immunol (1988) 1.00
Rab11A controls the biogenesis of Birbeck granules by regulating Langerin recycling and stability. Mol Biol Cell (2007) 0.98
Alpha IIb beta 3 integrin dissociation induced by EDTA results in morphological changes of the platelet surface-connected canalicular system with differential location of the two separate subunits. J Cell Biol (1993) 0.85
Phagocytic capacity of leucocytes in sheep mammary secretions following weaning. J Anat (2002) 0.83
Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A (1998) 4.99
Tumors arising in nevus sebaceus: A study of 596 cases. J Am Acad Dermatol (2000) 4.60
Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study. J Clin Oncol (2004) 3.97
A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res (1999) 3.19
Cloning and characterization of cDNAs for murine macrophage inflammatory protein 2 and its human homologues. J Exp Med (1990) 2.44
Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest (1999) 2.34
A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med (1997) 2.29
[Survival after cutaneous metastasis: a study of 200 cases]. Ann Dermatol Venereol (2001) 2.26
Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat Med (1996) 2.26
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study. Dermatology (1992) 2.13
Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation Factor IX gene. J Clin Invest (1984) 2.07
Chronic urticaria is not significantly associated with hepatitis C or hepatitis G infection: a case-control study. Arch Dermatol (1999) 1.93
Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J Immunol (1999) 1.92
Staphylococcal scalded skin syndrome in adults. A clinical review illustrated with a new case. J Am Acad Dermatol (1994) 1.90
Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science (1994) 1.88
Human epidermal Langerhans cells cointernalize by receptor-mediated endocytosis "nonclassical" major histocompatibility complex class I molecules (T6 antigens) and class II molecules (HLA-DR antigens). Proc Natl Acad Sci U S A (1987) 1.82
Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol (2002) 1.81
Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol (2012) 1.77
Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med (2001) 1.75
Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI). J Exp Med (1992) 1.72
The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett (1997) 1.70
Nail changes in patients infected with human immunodeficiency virus. A prospective controlled study. Arch Dermatol (1998) 1.69
Genetic screening for hemophilia A (classic hemophilia) with a polymorphic DNA probe. N Engl J Med (1985) 1.67
Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin. Cancer Res (2001) 1.63
The Schnitzler syndrome. Four new cases and review of the literature. Medicine (Baltimore) (2001) 1.62
Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist. Eur J Pharmacol (2001) 1.59
Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol Biol Cell (2001) 1.57
Erythema nodosum and associated diseases. A study of 129 cases. Int J Dermatol (1998) 1.56
Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. Br J Haematol (1995) 1.55
Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients. Br J Dermatol (2005) 1.54
Early markers for protective mechanisms during rush venom immunotherapy. Allergy (2010) 1.50
Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J Eur Acad Dermatol Venereol (2012) 1.49
Retinitis pigmentosa: rod photoreceptor rescue by a calcium-channel blocker in the rd mouse. Nat Med (1999) 1.49
The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation. Blood (1998) 1.48
Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells. J Immunol (2000) 1.47
Prevalence and significance of anticardiolipin antibodies in Crohn's disease. Dig Dis Sci (1994) 1.47
Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus. A study of 177 patients. Arch Dermatol (1996) 1.46
Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. J Allergy Clin Immunol (2001) 1.45
Aggregation of rabbit platelets by platelet-activating factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane-active drugs. Lab Invest (1979) 1.44
Safety of rush insect venom immunotherapy. The results of a retrospective study in 178 patients. Allergy (2003) 1.44
Sensitivity and long-term prognostic value of cardiac troponin-I increase shortly after percutaneous transluminal coronary angioplasty. Clin Cardiol (1998) 1.43
Epithelial sheath neuroma: a new entity. Am J Surg Pathol (2000) 1.40
[Atopic dermatitis. Version (17 July 2002 - modified final version)]. J Dtsch Dermatol Ges (2003) 1.39
[1492-1992: 500 years ago Christopher Columbus rediscovered America. From the rediscovery of skin diseases already described]. Ann Dermatol Venereol (1992) 1.39
Unusual particles and crystals in Crohn's disease granulomas. Lancet (1991) 1.39
[Lymph node and cutaneous syndrome associated with bone plasmacytoma]. Ann Dermatol Venereol (1997) 1.39
[Serotonin syndrome in acute poisoning with antidepressive agents]. Ann Fr Anesth Reanim (1996) 1.39
Leprosy type 1 reaction as the first manifestation of borderline lepromatous leprosy in a young native German. Br J Dermatol (1997) 1.39
[Unusual site of an embryonal rhabdomyosarcoma of the mesenchymal hepatic pedicle]. Ann Pathol (1999) 1.39
Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy (2007) 1.39
[Melanoma in the Strasbourg University Hospital. A 30-year study]. Ann Dermatol Venereol (1998) 1.38
Aphid transmission of beet western yellows luteovirus requires the minor capsid read-through protein P74. EMBO J (1995) 1.35
Mechanisms of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187. J Lab Clin Med (1977) 1.35
LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock. Am J Respir Crit Care Med (1999) 1.35
Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). J Exp Med (1998) 1.31
New treatment modalities for granuloma faciale. Br J Dermatol (2003) 1.31
Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol (1996) 1.31
In situ detection of lipid peroxidation by-products in chronic liver diseases. Hepatology (1997) 1.30
A "distant" bystander effect of suicide gene therapy: regression of nontransduced tumors together with a distant transduced tumor. Hum Gene Ther (1997) 1.25
Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost (2005) 1.25
Role of B cell receptor Ig alpha and Ig beta subunits in MHC class II-restricted antigen presentation. Immunity (1995) 1.25
Bowenoid papulosis. Presence of human papillomavirus (HPV) structural antigens and of HPV 16-related DNA sequences. Arch Dermatol (1985) 1.24
Cellular localization of a vasoactive intestinal peptide in the mammalian and avian gastrointestinal tract. Gut (1974) 1.24
Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis. Clin Exp Dermatol (2006) 1.22
In vitro and in vivo functions of thrombin-treated platelets. Thromb Haemost (1976) 1.22
Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors. Thromb Haemost (2000) 1.21
Cloning and expression of a cDNA coding for the anticoagulant hirudin from the bloodsucking leech, Hirudo medicinalis. Proc Natl Acad Sci U S A (1986) 1.20
Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy (2008) 1.20
A skin homing molecule defines the langerhans cell progenitor in human peripheral blood. J Exp Med (1997) 1.18
Clinical and immunological aspects of HLA class I deficiency. QJM (2005) 1.18
Management of dermatofibrosarcoma protuberans with fibrosarcomatous transformation: an evidence-based review of the literature. J Eur Acad Dermatol Venereol (2011) 1.18
HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. J Clin Invest (1999) 1.18
Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases. Dermatology (1999) 1.18
Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist. Circulation (2001) 1.17
Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes. Virology (2000) 1.16
Clq inhibition of the interaction of collagen with human platelets. J Immunol (1976) 1.16
The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin--a phosphoinositide 3-kinase-dependent mechanism. FEBS Lett (2001) 1.15
[Malignant eccrine poromas (poro-epitheliomas, porocarcinomas)]. Ann Anat Pathol (Paris) (1976) 1.15
The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel. Br J Haematol (1998) 1.15
Presence of P2X1 purinoceptors in human platelets and megakaryoblastic cell lines. Thromb Haemost (1997) 1.14
Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? Allergy (2008) 1.14
Arterial thrombosis and protein S deficiency. Thromb Haemost (1989) 1.13
The human platelet ADP receptor activates Gi2 proteins. Biochem J (1995) 1.12
Effects on platelet function of removal of platelet sialic acid by neuraminidase. Lab Invest (1975) 1.12
ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of Galphaq. Blood (2000) 1.12
Adherence of platelets to a collagen-coated surface: development of a quantitative method. J Lab Clin Med (1973) 1.12
Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas. Oncogene (2000) 1.11
The high-affinity IgE receptor (FcepsilonRI) blocks apoptosis in normal human monocytes. J Clin Invest (2000) 1.10
Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA. Br J Dermatol (2005) 1.10
Characterization of CD1e, a third type of CD1 molecule expressed in dendritic cells. J Biol Chem (2000) 1.09